H19/TET1 axis promotes TGF‐β signaling linked to endothelial‐to‐mesenchymal transition. Issue 6 (6th May 2020)

• Record Type: Journal Article
• Authors: Cao, Tiefeng; Jiang, Ying; Li, Da; Sun, Xiaoli; Zhang, Yuanyuan; Qin, Lingfeng; Tellides, George; Taylor, Hugh S.; Huang, Yingqun
• Is Part Of: FASEB journal. Volume 34:Issue 6(2020)
• Page Start: 8625
• Page End: 8640
• Publication Date: 2020-05-06
• Subjects: atherosclerosis -- cardiovascular -- EndMT -- epigenetic -- LncRNA; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202000073RRRRR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: While emerging evidence suggests the link between endothelial activation of TGF‐β signaling, induction of endothelial‐to‐mesenchymal transition (EndMT), and cardiovascular disease (CVD), the molecular underpinning of this connection remains enigmatic. Here, we report aberrant expression of H19 lncRNA and TET1 in endothelial cells (ECs) of human atherosclerotic coronary arteries. Using primary human umbilical vein endothelial cells (HUVECs) and aortic endothelial cells (HAoECs) we show that TNF‐α, a known risk factor for endothelial dysfunction and CVD, induces H19 expression which in turn activates TGF‐β signaling and EndMT via a TET1‐dependent epigenetic mechanism. We also show that H19 regulates TET1 expression at the posttranscriptional level. Further, we provide evidence that this H19/TET1‐mediated regulation of TGF‐β signaling and EndMT occurs in mouse pulmonary microvascular ECs in vivo under hyperglycemic conditions. We propose that endothelial activation of the H19/TET1 axis may play an important role in EndMT and perhaps CVD.